Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Part of the PlexusDx Education Hub: independent, evidence-led coverage of GLP-1 programs, weight-management protocols, and the genetics that sit beneath the numbers. Browse all Peptides & GLP-1 education
An independent editorial review. PlexusDx has no commercial relationship with Hers or its parent, and no affiliate links or compensation are involved.
Hers is one of many telehealth programs in the GLP-1 and weight-management space. Rather than quote a single sticker price, this review breaks down how the program is priced: the subscription mechanics, what a monthly charge does and does not include, and the factors that move the total. Fair-balance framing, not a buying recommendation. Current as of April 2026.
Start your GLP-1 program with PlexusDx
One all-inclusive price covers your online provider visit, prescription, compounded medication, and shipping — no membership, no hidden fees. Complete a short intake and a licensed provider takes it from there.
Start your intake →
What actually drives a Hers monthly charge
Hers, the women's brand of Hims & Hers Health, bills weight management as a subscription rather than a one-time purchase. The number you see is a bundle: a remote clinical evaluation by a licensed provider, the prescription itself, pharmacy fulfillment, and ongoing follow-up. What pushes that bundle up or down is the medication selected, the subscription tier, and whether the brand routes you to a retail pharmacy for an FDA-approved brand product or to a 503A compounding pharmacy for compounded semaglutide or tirzepatide. Current pricing is published on Hers's official website.
How the subscription mechanics work
A typical charge recurs monthly and folds the clinical and pharmacy costs together, which is why a headline figure can be hard to compare across brands. Program fees, medication cost, and total monthly spend each move independently. Across the telehealth GLP-1 market as of April 2026, monthly totals generally fall between roughly $200 and $700+, with wide variance depending on compound, tier, and dispensing path. Verify the live number at Hers's official website before you commit, since these change frequently.
The compounds your spend is paying for
Cost is ultimately tied to the molecule. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the dual GIP/GLP-1 agonist tirzepatide carry the clinical evidence: STEP for semaglutide (The New England Journal of Medicine, 2021), SURMOUNT for tirzepatide (NEJM, 2022), and SURMOUNT-OSA for tirzepatide in obstructive sleep apnea (NEJM, 2024). Endpoints and populations vary between trials, and results vary by person.
A transparent-pricing point of comparison
For readers comparing cash-pay structures, PlexusDx lists its weight-management protocols openly rather than revealing a price only after intake: Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a microdose option at a flat $129 per month. The Precision Peptide Genetic Test is $298. Those figures are shown up front so the math is clear before you start.
The variable no monthly charge accounts for
The one input the price sheet never captures is your own biology. Telehealth programs like this one do not examine the upstream genetic architecture that shapes every GLP-1 response. Variants in FTO (the fat-mass and obesity-associated gene), GLP1R (the GLP-1 receptor gene, the direct target of every GLP-1 compound), MC4R (a melanocortin receptor central to satiety and energy balance), and TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion) map the baseline metabolic terrain any compound acts on. These are pathway-level markers. They do not predict response to a specific medication, but they describe the biology a clinician is prescribing into, context a prescription alone never captures.
PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols, available as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What distinguishes the approach is that upstream genetic context. Before starting any GLP-1 pathway protocol, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO and MC4R, and TCF7L2 that shape your baseline GLP-1, appetite-regulation, and energy-balance biology. Reading that profile alongside the protocol is the test before you invest approach, turning guesswork into an informed conversation with your healthcare provider.
Not affiliated: PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed in this article.
Related reading on PlexusDx: GLP 1 Drugs, GLP 1 Hormone, What Is GLP 1, GLP 1 What Is.
Disclaimer: This article is educational. PlexusDx is not affiliated with Hers and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches in the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.
Compare the cost structure directly: see the Weight Management Protocols, semaglutide and tirzepatide paired with the genetic context most telehealth programs omit. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.
Frequently Asked Questions About Hers Cost
What determines the monthly cost of a Hers program?
The total reflects the medication selected, the subscription tier, and whether dispensing runs through a retail pharmacy for a brand product or a 503A compounding pharmacy. Program fees and medication cost are bundled into a recurring charge, which is why headline figures vary so widely between brands.
Is Hers billed as a subscription?
Yes. Weight-management telehealth of this kind typically recurs monthly and folds the clinical evaluation, prescription, and pharmacy fulfillment into one charge. Across the market as of April 2026, monthly totals generally fall between roughly $200 and $700+, with wide variance by compound and tier.
Does insurance offset the cost?
Cash-pay compounded telehealth generally operates outside insurance billing, so the posted price is usually what you pay. Confirm current figures on the brand's own site before committing, since a compounded, cash-pay model rarely involves a pharmacy benefit or formulary discount.
How does PlexusDx price its protocols?
PlexusDx lists pricing up front: Semaglutide Injection at $189 per month, Tirzepatide Injection at $289 per month, and a microdose at a flat $129 per month. The Precision Peptide Genetic Test is $298, so the math is clear before you start.
This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Henry Meds and Tirzepatide: Compounded Model and Pricing
Henry Meds GLP-1 Program: Medications, Steps, and Pricing